Latest News

New NYU Abu Dhabi Research Could Make Cancer Treatments More Efficient

The findings will help in the development of drugs that could increase the effectiveness of existing treatments A team led by Professor of Biology, Senior Vice Provost of Research at NYU Abu Dhabi, and UAE national Sehamuddin Galadari, has discovered a novel structural modification in AMP-activated protein kinase (AMPK) during anticancer therapy that could pave the way for the development of more effective cancer treatments. AMPK normally works as the cellular energy sensor that is activated when there is a shortage of energy in the body. Once activated, AMPK kickstarts events in the cell that restore the energy balance. The major component of AMPK exists as two isoforms (functionally similar proteins) - AMPK-⍺1 and AMPK-⍺2. In a paper titled Caspase cleavage and nuclear retention of the

Dementia vaccines: What are they, and when could they become available?

Vaccines are arguably one of the greatest inventions of medical science of all time. Now, researchers are looking to take vaccine technology one step further to protect against neurodegenerative diseases like dementia. In this Special Feature, we asked experts about what is currently under development, how a dementia vaccine would work, and how quickly we may see one becoming available to the public. Dementia is an umbrella term referring to a range of disorders that affect the way in which a person’s brain works, causing symptoms including memory loss, behavior changes, and difficulty speaking and walking. The most common form of dementia is Alzheimer’s disease, which accounts for 60% to 80% of dementia cases. More than 55 million people around the world have dementia, with about 10

‘Goldilocks zone’: UC Researchers Seek to Improve Emergency Care

Venture Lab-backed startup develops device to help provide rescue breathing. Technology from a University of Cincinnati Venture Lab-backed startup could save lives by allowing emergency medical personnel to accurately monitor the life-saving treatment they provide. The startup, Spiritus, was founded by three UC

NYC Health + Hospitals Upgrading Hundreds of Imaging Machines In $224M Deal with GE Healthcare

NYC Health + Hospitals plans to upgrade hundreds of medical imaging technologies across the health system over the next 10 years as part of a $224 million deal with GE Healthcare. The health system operates 470 imaging machines—including MRI, CT, nuclear cameras, X-ray machines, catheterization labs, PET/PETCT machines and fluoroscopy units—across its 11-hospital footprint. Half of those medical imaging units, about 230, will be replaced and updated within the first four years of the project, health system officials said. NYC Health + Hospitals is the largest public healthcare system in the nation serving more than a million New Yorkers annually and operating 70 patient care locations in the city's five boroughs. The organization performs 1.5 million imaging procedures each year. The

Medical Anesthesia Devices Market Size, Share & Growth

According to Coherent Market Insights, the global anesthesia devices market is estimated to be valued at US$ 14,977.9 billion in 2022 and is expected to exhibit a CAGR of 7.6 % during the forecast period (2022-2030). Anesthetic devices give correct associated continuous provider of medical gases mixed with a correct
Medical Equipment

How do Anesthesia Machines Work?

Imagine going under surgery without anesthesia. Undoubtedly, fear among patients scheduled for surgical procedures is pervasive. Some professionals even attribute patient anxiety to the fear of the anesthetic itself but understanding how doctors administer anesthesia can be incredibly beneficial to easing the tension of a worried patient. After all—the more we know, the less we fear. Anesthesia machines are one of the most versatile medical instruments in the healthcare industry. The pneumatic devices help doctors sedate their patients before surgery and keep them asleep, while breathing, throughout the procedure. Primarily, the function of the anesthesia machine is to help surgeons mitigate their patient’s pain during a medical operation. In this sense, anesthesia machines become a

Global Sterilization Equipment Market Report (2022 to 2030)

Sterilization is described as a complete elimination or destruction of all microbial life forms, carried out by various methods using sterilization equipment. Medical devices are sterilized in various ways, including using moist heat (steam), dry heat, radiation, ethylene oxide gas, vaporized hydrogen peroxide, and

Citizens Medical Center Lab Shows Off New Robotic Lab Equipment

Citizens Medical Center showcased new robotic laboratory equipment that is expected to cut down on testing time significantly. The robotic equipment, titled the Abbott project, cost $1.5 million and took 18-months to plan and transition to it as it came online in late July. It was showcased at a Tuesday hospital board
Product Focus

New HeartBeam Patent for 12-Lead Electrocardiogram (ECG) Smartwatch-based Monitor Intended for Detection of Heart Attacks and Complex Cardiac Arrhythmias

HeartBeam, Inc., a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform for heart attack detection anytime, anywhere, announced today that its patent for a 12-lead electrocardiogram (ECG) smartwatch-based monitor intended for detection of heart attacks and complex cardiac arrhythmias was allowed by the United States Patent and Trademark Office. The innovation builds on HeartBeam’s growing intellectual property portfolio enabling 12-lead ECG diagnostics outside of a medical setting. The global wearables medical device market is estimated to reach $196B by 2030 and encompasses a wide variety of capabilities, including diagnostic monitoring such as heart rate and some cardiac arrhythmias, blood pressure, glucose, respiratory, and sleep

FDA Clears Syringe Infusion Pump With Dose IQ Software From Baxter

Baxter (NYSE:BAX) announced today that the FDA issued 510(k) clearance to its Novum IQ infusion pump with Dose IQ safety software. Deerfield, Illinois-based Baxter designed its new Novum IQ syringe infusion pump (SYR) to deliver small amounts of fluid at low rates. It includes a technologically integrated user

Study Uncovers a Previously Unknown Propofol Effect in Neurons

Propofol is the most used drug to induce general anesthesia. Despite its frequent clinical application, it is poorly understood how propofol causes anesthesia. In a new study published in Molecular Biology of the Cell, a team of Rensselaer Polytechnic Institute researchers identified a previously unknown propofol effect in neurons. The study found that propofol exposure impacted the process by which neurons transport proteins, biomolecules that perform most cellular functions, to the cell surface. Almost all animal cells, including human cells, are highly compartmentalized and rely on efficient movement of protein material between compartments. Proteins are moved from their site of synthesis to the location at which they perform their function in small carriers called "vesicles." This

Antihypertensive Drugs Market worth USD 41 Bn by 2030 at a CAGR of 3.45%

The global Antihypertensive Drugs market size is expected to be worth around US$ 41 billion by 2030, according to a new report by Nova one advisor. The global Antihypertensive Drugs market size was valued at US$ 30.8 billion in 2021 and is anticipated to grow at a CAGR of 3.45% during forecast period 2022 to 2030.

Using AI to Find New Antibiotics Still a Work in Progress

Each year, more than 2.8 million people in the United States develop bacterial infections that don’t respond to treatment and sometimes turn life-threatening [1]. Their infections are antibiotic-resistant, meaning the bacteria have changed in ways that allow them to withstand our current widely used arsenal of
Campaigns & Recent Studies

PT027 Recommended by FDA Advisory Committee as New Rescue Treatment for Asthma

PT027 is a potential first-in-class, pressurized metered-dose inhaler (pMDI), fixed-dose combination rescue medication in the US containing albuterol, a short-acting beta2-agonist (SABA), and budesonide, an anti-inflammatory inhaled corticosteroid (ICS). It is being developed by AstraZeneca and Avillion. In the first half of 2022, the FDA accepted the New Drug Application (NDA) for PT027 and set a Prescription Drug User Fee Act date for the first half of 2023. Bradley E. Chipps, Past President of the American College of Allergy, Asthma & Immunology and Medical Director of the Capital Allergy & Respiratory Disease Center in Sacramento, US, said: “Millions of people with asthma rely on their albuterol rescue inhaler to alleviate acute symptoms, but this does not treat the underlying

Geriatric Medicines Market Size

Geriatric Drugs Market Size Is Estimated to Be $1.5 Billion By 2027, Growing at A CAGR Of 6.5% During the Forecast Period 2022-2027. The geriatric drug market size is estimated to be $1.5 billion by 2027, growing at a CAGR of 6.5% during the forecast period 2022-2027. Geriatrics or geriatric medicine is a specialty
Diet & Nutrition

Nutrabolt Partners with Biotech AI Leader Nuritas to Launch Testosterone Booster

Human performance company Nutrabolt has launched their new Testosterone Booster supplement named Cellucor P6 Ultimate, powered by Nuritas using the next generation of intelligent ingredients unlocked from nature, using AI. This new product, aimed at men, supports healthy testosterone levels, strength, and endurance, maximizing overall physical performance. Cellucor features Nuritas’ powerful patented ingredient PeptiStrong, which harnesses cell-signaling technology to bring nutraceuticals beyond nutrition. The inclusion of PeptiStrong provides a wide range of benefits thanks to its multi-dimensional effects on muscle health: promoting muscle strength, improving recovery after intense exercise, boosting energy and supporting the synthesis of protein that assists in maintaining and building

Global Glucomannan Market

Global Glucomannan Market size is expected to reach nearly US$ 1.67 Bn by 2026 with the CAGR of 3.2% during the forecast period. Global Glucomannan Market Overview: Glucomannan is a highly water-soluble dietary fiber made from the roots of the Konjac plant. Glucomannan consists of proteins that are sweet to taste along

Gatorade Adds Caffeine to Its Lineup with Energy Drink Fast Twitch

Key Points Gatorade is entering the energy drink category with a caffeinated spin-off called Fast Twitch. The new drink is slated to launch in February, but NFL players will be drinking it on sidelines during the upcoming season as part of an exclusive deal with the league. A bottle of Fast Twitch contains nearly as
Country Reports

China's Health Insurance Reform Won't Cut Benefits, Unrelated To COVID: Experts

A number of Chinese localities, including Central China's Hubei, Southwest China's Sichuan and Northeast China's Heilongjiang, are implementing a reform of health insurance for urban employees and retirees, drawing widespread attention. Industry observers said the reform, which reduces the amount deposited each month into personal accounts, doesn't mean the reduction or loss of health insurance benefits, nor is it a move to cover COVID-19-related expenses, as some Western media asserted. The health insurance reform is a decision that has been made after years of discussion, planning and prudent consideration and places Chinese families in a better position to cope with medical risks, and elderly people who are more susceptible to illness and incur higher medical expenses will benefit the


In France, the term ‘probiotic’ can be used as well as the claim “contributes to the balance of the intestinal flora”, under certain conditions In January 2023 France joined a growing movement of countries allowing the use of the term ‘probiotic’ in food and food supplements. France states that the term probiotic

‘Major Milestone’: Ground-Breaking NZ Cancer Therapy Closer to Reality

Scientists have moved a step closer to bringing a ground-breaking cancer therapy to Kiwis, after treating the final patient in a first-of-its-kind medical trial. The Malaghan Institute’s ENABLE trial is working toward a new treatment for certain types of lymphoma – a blood cancer and the sixth-most common type of

Arab Health anticipates 3,000 companies from 70 countries for its next edition in January

The 2023 edition of Arab Health will return to the Dubai World Trade Centre from 30th January – 2nd February under the show's theme, 'Innovation and Sustainability in Healthcare', the organizers said. Exhibitor companies are also anticipated to rise, increasing from 2,828 to over 3,000 from 70 countries, according to Informa Markets. Arab Health has underscored its position as the epicenter of healthcare trade and reaffirmed its support for global businesses and governments by securing AED2.8 billion worth of healthcare industry-related contracts, according to a GRS Explore Exhibitor Survey during the 2022 edition, which was held in Dubai in January. The exhibition plays an integral role in supporting UAE Government initiatives such as ‘Make it in the Emirates’, a platform for developing



Japan Emergency & Medical Care Conference




DECODE: AI for Pharmaceutical Executives




Vision Expo East


Medicall Hyderabad

South Korea

Korea International Medical & Hospital Equipment Show


Southeast Asian Healthcare & Pharma Show


The Middle East’s Dedicated Precision Medicine Exhibition & Summit.